NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

Shuttle Pharmaceuticals logo
$4.30 +0.06 (+1.42%)
Closing price 03:59 PM Eastern
Extended Trading
$4.18 -0.12 (-2.88%)
As of 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Advanced

Key Stats

Today's Range
$3.61
▼
$4.70
50-Day Range
$3.13
▼
$5.59
52-Week Range
$2.58
▼
$44.40
Volume
63,269 shs
Average Volume
29,344 shs
Market Capitalization
$20.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing treatments intended to improve outcomes for patients receiving radiation therapy for cancer. The company is based in Rockville, Maryland.

Its lead drug candidate, ropidoxuridine, is an oral prodrug designed to make cancer cells more sensitive to radiation. Shuttle has studied the candidate in combination with radiation therapy, including for patients with glioblastoma, an aggressive form of brain cancer.

The company’s research also includes developing personalized cancer treatments and other drug candidates intended to enhance the effects of radiation. Its work is primarily focused on cancer treatment research and development.

AI Generated. May Contain Errors.

Shuttle Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

SHPH MarketRank™: 
1.09466277217 of 5 stars

Shuttle Pharmaceuticals scored higher than 22% of companies evaluated by MarketBeat, and ranked 496th out of 583 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Shuttle Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Shuttle Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.

  • Read more about Shuttle Pharmaceuticals' stock forecast and price target.
  • Price to Book Value per Share Ratio

    Shuttle Pharmaceuticals has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.31% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.54, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently decreased by 52.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Shuttle Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Shuttle Pharmaceuticals does not have a long track record of dividend growth.

  • News Sentiment

    Shuttle Pharmaceuticals has a news sentiment score of 1.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Shuttle Pharmaceuticals this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Shuttle Pharmaceuticals to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Shuttle Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.36% of the stock of Shuttle Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    4.58% of the stock of Shuttle Pharmaceuticals is held by institutions.

  • Read more about Shuttle Pharmaceuticals' insider trading history.
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SHPH Stock News Headlines

Shuttle Pharmaceuticals Reports Delay in Quarterly Filing
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
See More Headlines

SHPH Stock Analysis - Frequently Asked Questions

Shuttle Pharmaceuticals' stock was trading at $18.00 at the beginning of 2026. Since then, SHPH stock has decreased by 76.1% and is now trading at $4.30.

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) issued its quarterly earnings results on Thursday, May, 8th. The company reported ($75.00) earnings per share (EPS) for the quarter.

Shares of Shuttle Pharmaceuticals reverse split before market open on Thursday, June 11th 2026.The 1-10 reverse split was announced on Tuesday, June 9th 2026. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 10th 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shuttle Pharmaceuticals (SHPH) raised $10 million in an initial public offering (IPO) on Tuesday, August 30th 2022. The company issued 1,225,888 shares at a price of $8.13 per share.

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shuttle Pharmaceuticals investors own include NVIDIA (NVDA), Tesla (TSLA), Applied Digital (APLD), AST SpaceMobile (ASTS), Intel (INTC), Micron Technology (MU) and BigBear.ai (BBAI).

Company Calendar

Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Software
Sub-Industry
Application Software
Current Symbol
NASDAQ:SHPH
CIK
1757499
Fax
N/A
Employees
2
Year Founded
2012

Profitability

EPS (Trailing Twelve Months)
($18.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.72 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-168.34%
Return on Assets
-90.59%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$11.14 per share
Price / Book
0.39

Miscellaneous

Outstanding Shares
4,760,000
Free Float
4,748,000
Market Cap
$20.47 million
Optionable
Not Optionable
Beta
-0.04

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:SHPH) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners